Get started
Esperion Therapeutics, Inc. 4.0% 15-NOV-2025Esperion Therapeutics, Inc. 4.0% 15-NOV-2025Esperion Therapeutics, Inc. 4.0% 15-NOV-2025

Esperion Therapeutics, Inc. 4.0% 15-NOV-2025

No trades
See on Supercharts
Overview
Analysis News

PFE5307022 chart


Full chart

Key terms


Outstanding amount
‪265.00 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
4.00% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
8.63%
Maturity date
Nov 15, 2025
Term to maturity
1 year

About Esperion Therapeutics, Inc. 4.0% 15-NOV-2025


Issuer
Esperion Therapeutics, Inc.
Sector
Health Technology
Home page
esperion.com
Issue date
Dec 18, 2021
FIGI
BBG00Y60CH98
Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

News